Salah Eddin Al-Batran, Prof. Dr.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Florian Lordick, Prof. Dr.
Universitätsklinikum Leipzig
Shared therapeutic areas:
Worked with same sponsors:
Sylvie Lorenzen, Prof. Dr.
Klinikum München rechts der Isar der Technischen Universität München
Shared therapeutic areas:
Worked with same sponsors:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Manish Shah, MD
Weill Medical College of Cornell University
Shared therapeutic areas:
Hyun Kim, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
jiafu ji, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Kezhong Chen, MD
Peking University People's Hospital
Shared therapeutic areas:
Julian Abrams, MD
Columbia University
Shared therapeutic areas:
Zhen Zhang, MD
Fudan University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
All 2 trials loaded